ANNUAL FINANCIAL REPORT 2010 2010 - TiGenix

Noyes, F. R., Barber-Westin, S. D., (2002) Arthroscopic repair of meniscal tears extending into the avascular zone in patients youngerthan twenty years of age, Am J Sports Med. Jul-Aug;30(4):589-600.Panés, Gomollón, Taxonera et al. “Crohn’s Disease. A Review of Current Treatment with a Focus on Biologics Drugs”. 2007; 67 (17): 2511-2537.Peterson, L., Minas, T., Brittberg, M., Nilsson, A., Sjogren-Jansson, E., and Lindahl, A. (2000) Two- to 9-year outcome after autologouschondrocyte transplantation of the knee. Clin.Orthop. 212-234Peterson, L., Brittberg, M., Kiviranta, I., Akerlund, E. L., and Lindahl, A. (2002) Autologous chondrocyte transplantation. Biomechanicsand long-term durability. Am.J.Sports Med. 30: 2-12Psoriasis Drugs: A Global Strategic Business Report. Global Industry Analysts.“Rheumatoid Arthritis – Drug Pipeline Analysis аnd Market Forecasts tο 2015”. Global Industry Analysts.Rosenzweig, A. (2006) Cardiac cell therapy--mixed results from mixed cells. N.Engl.J.Med. 355: 1274-1277Salaffi, F., De, Angelis R., Stancati, A., and Grassi, W. (2005) Health-related quality of life in multiple musculoskeletal conditions: a crosssectionalpopulation based epidemiological study. II. The MAPPING study. Clin.Exp.Rheumatol. 23: 829-839Saris, D. B., Vanlauwe, J., Victor, J., Haspl, M., Bohnsack, M., Fortems, Y., Vandekerckhove, B., Almqvist, K. F., Claes, T., Handelberg, F., Lagae,K., van der, Bauwhede J., Vandenneucker, H., Yang, K. G., Jelic, M., Verdonk, R., Veulemans, N., Bellemans, J., and Luyten, F. P. (2008)Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee ina randomized controlled trial versus microfracture. Am J Sports Med 36: 235-246Saris, D. B., Vanlauwe, J. (2009) A prospective, randomized controlled trial of ChondroCelect versus microfracture in the repair ofsymptomatic cartilage defects of the knee, follow up at 36 months. Am J Sports Med., Nov 2009;37 Suppl 1:10S-19S.Steinwachs M., (2009) New technique for cell-seeded collagen matrix-supported autologous chondrocyte transplantation. Arthroscopy,25: 208-11Stem Cells Dev. 2008 Aug;17(4):681-93.”Soluble factors-mediated immunomodulatory effects of canine adipose tissue-derivedmesenchymal stem cells.” Kang JW, Kang KS, Koo HC, Park JR, Choi EW, Park YH.Stürmer, K. M., Eulert, J., Weise, K., and Niethard, F. U. (2006) Gemeinsame Stellungnahme der AG ‘Geweberegeneration, Gewebeersatz’der Deutschen Gesellschaft für Unfallchirurgie und der Deutschen Gesellschaft für Orthopädie und Orhtopädische Chirurgie. EU-Kommissionsentwurf ‘Advanced therapies’Systemic Lupus Erythematosus - Pipeline Assessment and Market Forecasts to 2017 Aarkstore.Tanna, S. (2004) Osteoarthritis - Opportunities to address pharmaceutical gaps.The Bone and Joint Decade, The Global Economic and Healthcare Burden of Musculoskeletal Disease;http://www.boneandjointdecade.orgThe Future of Autoimmune Diseases Therapeutics – Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and DealAnalysis. GBI Research Dec 2009.US Department of Health and Human Services (2006) A new vision - A future for regenerative medicine. US Department of Health andHuman ServicesVander CB, 2006.Verdonk, R. Steinwachs M. Vanlauwe J. Engebretese L. (2006) Trends in cartilage repair. Current opinion of orthopaedic surgeons oncartilage repair: the results of a global web-based survey. ESSKA245 •